HIF1A and COVID-19: In accordance with our previously published data [31], we confirmed a significant increase in both the OxS markers TBARS and HIF-1α and the antioxidant CAT and SOD1 enzymes in COVID-19-positive placentae compared to COVID-19-negative controls, emphasizing the placental ability to counteract COVID-19-induced OxS during pregnancy.